Kiora Pharmaceuticals, Inc. - Common Stock (KPRX)

KPRX stock results show that Kiora Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.

KPRX stock results show that Kiora Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.

We are starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to read about this morning!

Shares of Meta Platforms, Inc. (NASDAQ: META) rose sharply in today’s pre-market trading as the company reported upbeat fourth-quarter financial results and initiated a quarterly dividend of 50 cents per share.

Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarter financial results.

We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers worth keeping tabs on Friday!

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.

Kiora Pharmaceuticals also entered into a securities purchase agreement with certain institutional investors, pursuant to which Kiora agreed to issue and sell 15,800,000 shares and warrants for expected aggregate gross proceeds at closing of approximately $15 million and potential future warrant exercise gross proceeds of approximately $30 million.

Plug Power stock is heading higher on Thursday as investors in the company celebrate it producing green fuel at its Georgia plant.

Infobird stock is falling on Thursday after the company announced plans for a reverse stock split to boost the price of IFBD shares.

Revelation Biosciences stock is falling on Thursday after the company announced the price of a public offering for REVB shares.

Kiora Pharmaceuticals stock is rising higher on Thursday as KPRX investors react to a new $45 million private placement.